No Data
hitgen inc. (688222): The performance steadily rebounded in the first three quarters, creating new momentum for drug research and development with "DEL+AI+automation".
Revenue in the first three quarters increased by 21.4% year-on-year, with various technological platforms accelerating commercial transformation. The company achieved annual revenue of 0.371 billion yuan in 2023 (+12.6%), net income attributable to shareholders of 0.041 billion yuan (+61.2%), after deducting non-recurring items.
Hitgen Inc. (688222) 2024 third quarter report review: Main business achieves accelerated growth, commercial projects progress steadily.
Event: On October 26, 2024, hitgen inc. released the third quarter report of 2024, achieving revenue of 0.298 billion yuan in the first three quarters, a year-on-year growth of 21.38%; net income attributable to the parent company was 30.1203 million yuan, the same.
hitgen inc. (688222): Q3 shows a gradually recovering trend, bullish on the long-term development of the DEL platform.
Event: The company released the third quarter report of 2024. In the first three quarters of 2024, the company achieved revenue of 0.298 billion yuan, a year-on-year increase of 21.38%; net income attributable to the parent company was 30.12 million yuan, a year-on-year increase of 64.71%; excluding non-recurring items.
Chengdu Pilot Drug Development Co., Ltd. Report for the Third Quarter of 2024
hitgen inc. (688222.SH): The profit for the first three quarters was 30.12 million yuan, a year-on-year increase of 64.71%.
Grainnews Oct. 25th | Hitgen Inc. (688222.SH) released its third-quarter report, with revenue of 0.298 billion yuan in the first three quarters, a year-on-year increase of 21.38%, net income of 30.12 million yuan, a year-on-year increase of 64.71%, non-GAAP net income of 17.31 million yuan, a year-on-year increase of 6831.94%, and basic earnings per share of 0.08 yuan.
Express News | hitgen inc.: net income in the first three quarters was 30.1203 million yuan, a year-on-year increase of 64.71%.
No Data
No Data